Medicine & Life Sciences
Neoplasms
100%
Ovarian Neoplasms
76%
Breast Neoplasms
61%
Mutation
40%
Genes
39%
Proteins
35%
Growth
31%
Phosphatidylinositol 3-Kinase
30%
Cell Line
30%
Apoptosis
29%
Phosphorylation
27%
lysophosphatidic acid
27%
Protein Array Analysis
23%
Therapeutics
22%
Survival
22%
Genome
20%
Phosphotransferases
20%
Gene Expression
20%
Neoplasm Metastasis
19%
Proteomics
19%
Hepatocellular Carcinoma
19%
MicroRNAs
18%
Biomarkers
17%
Carcinogenesis
17%
Phosphatidylinositol 3-Kinases
16%
T-Lymphocytes
16%
Atlases
16%
DNA Damage
16%
Cell Proliferation
15%
Ovarian Epithelial Carcinoma
15%
Heterografts
14%
Carcinoma
13%
DNA
13%
Messenger RNA
13%
Estrogen Receptors
13%
In Vitro Techniques
12%
Non-Small Cell Lung Carcinoma
12%
Lysophosphatidic Acid Receptors
12%
Cell Cycle
11%
Protein-Tyrosine Kinases
11%
Transcriptome
11%
Phenotype
11%
Down-Regulation
11%
Endometrial Neoplasms
11%
Drosophila
11%
Poly(ADP-ribose) Polymerase Inhibitors
11%
Drug Therapy
11%
Autophagy
11%
Glioblastoma
10%
Methylation
10%
Melanoma
10%
Cell Movement
10%
Triple Negative Breast Neoplasms
10%
Epithelial Cells
10%
Small Interfering RNA
10%
Recurrence
10%
Nasopharyngeal Carcinoma
10%
Up-Regulation
10%
DNA Repair
10%
Neoplasm Genes
10%
Squamous Cell Carcinoma of Head and Neck
10%
Oncogenes
10%
Mitogen-Activated Protein Kinase Kinases
10%
Tyrosine
10%
ErbB Receptors
9%
Cell Survival
9%
Interleukin-2 Receptors
9%
Lung Neoplasms
9%
Epigenomics
9%
Transcription Factors
9%
Neoplastic Stem Cells
8%
Intercellular Signaling Peptides and Proteins
8%
Cell Death
8%
Cisplatin
8%
Liver
8%
Adenocarcinoma
8%
Epithelial-Mesenchymal Transition
8%
High-Throughput Nucleotide Sequencing
8%
Phosphoric Monoester Hydrolases
8%
Long Noncoding RNA
8%
Tumor Microenvironment
8%
JNK Mitogen-Activated Protein Kinases
8%
RNA
7%
Breast
7%
Pharmaceutical Preparations
7%
Datasets
7%
Protein Kinase C
7%
Renal Cell Carcinoma
7%
Integrins
7%
TOR Serine-Threonine Kinases
7%
Stomach Neoplasms
7%
Ligands
7%
Colorectal Neoplasms
7%
Catenins
7%
avicin D
7%
Fibroblasts
7%
Glioma
7%
Prostatic Neoplasms
7%